nivolumab FDA approval date

The FDA approved nivolumab (Opdivo) on 22 Dec 2014.

FDA approval date
22 Dec 2014

Drug identity checked against registry records

Also recorded as Opdivo

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)NCT03767348Replimune, Inc.Phase 2Active not recruiting2028-06Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-12-22DaynivolumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125554", "applicant_as_listed_by_fda": "BRISTOL MYERS SQUIBB", "brand_names": ["OPDIVO"], "active_ingredients": ["NIVOLUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20141222", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026